$IX

Otsuka Takashi purchased $503 of IX

Otsuka Takashi (See Remarks) purchased 13 shares of ORIX CORP (IX) at $38.22 on 2026-05-20.

Original reporting
SEC EDGAR · Otsuka Takashi
Published Jun 25, 2026, 10:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 10:36 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IX
Neutral
low confidence
Mentioned
$IX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IXNeutralLow
01

Why it matters

This provides a fresh, primary-source datapoint on an officer’s small open-market purchase, but it does not include any new company-specific fundamentals (earnings, guidance, deals, or regulatory actions).

02

Market read

Traders may note the insider buy as a minor sentiment input, but it is unlikely to be a standalone catalyst.

03

What to watch

Insider buys can be driven by diversification, tax planning, or compensation mechanics; without context on prior trades or broader buying patterns, signal strength is limited.

Relevance 4/10Novelty 5/10Timing: Filed 2026-06-25; transaction dated 2026-05-20.

Background

The article is an SEC Form 4 insider transaction disclosure for ORIX Corp (IX).

Company-level read

Ticker impact

$IXNeutralLow confidence
Context

ORIX Corp is the Form 4 issuer, and Otsuka Takashi reported a $502.94 open-market purchase of 13 shares on 2026-05-20.

Expected impact

Low likelihood of a tradable price reaction; any impact would be sentiment-only and short-lived.

Evidence & confidence

The filing is primary-source (Form 4) but the dollar value (~$503) and share count (13) are small, with no new operational or guidance information.

Market effects

No sector read-through; this is a single, small insider transaction with no stated corporate action.

None indicated.

None indicated.

Counterpoint

The lack of a 10b5-1 plan and the small size could mean routine personal liquidity rather than a strong conviction signal.

Key entities

  • ORIX CORP

    Subject of the Form 4; insider transaction reported by Otsuka Takashi.

  • Otsuka Takashi

    Officer who reported an open-market purchase of 13 shares at $38.2200 on 2026-05-20.

Related articles

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.